Utah Medical Products, Inc.
NASDAQ:UTMDMedical - Instruments & Supplies
+$1.10 today
- Market cap
- $205.81M
- Beta
- 0.37
- P/E (TTM)
- 19.6
- EPS (TTM)
- $3.41
- Dividend yield
- 1.85%
Volume 0.02M
Average 0.01M
UTMD Total Current Liabilities
All obligations due within one year.
Utah Medical Products, Inc.NASDAQ: UTMD
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities falls 18.9% from a year ago
Total current liabilities stood at $3.51M at the end of Q1 FY2026, down 18.9% from a year earlier and up 34.9% from the prior quarter. Over 3 fiscal years it compounded at -24.2% a year.
Context
- Total current liabilities amounted to 2.8% of total assets at the end of Q1 FY2026, down 0.7 pp from a year earlier.
- Total current liabilities increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps falling in the next quarterly balance sheet after a -18.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 2.6M USD
- Year-over-year change
- -30.8%
- 4-year CAGR
- -8.7%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.6M | -30.8% |
| FY2024 | 2024-12-31 | 3.76M | -20.2% |
| FY2023 | 2023-12-31 | 4.71M | -21.0% |
| FY2022 | 2022-12-31 | 5.96M | +59.1% |
| FY2021 | 2021-12-31 | 3.75M | — |
Total Current Liabilities vs competitors
How UTMD compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -18.9% is the 9th highest of 11, against a peer median of +13.7%.
- Total current liabilities amounts to 2.8% of total assets for UTMD, versus a peer median of 20.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $132.33M USD | -48.1% | +0.8% | 49.7% | |
| Mar 2026 | $44.08M USD | +73.4% | -16.8% | 11.6% | |
| Mar 2026 | €41.21M EUR | +96.5% | +48.6% | 42.1% | |
| Mar 2026 | $31.49M USD | +148.3% | +120.5% | 7.7% | |
| Mar 2026 | $28.29M USD | +13.9% | -2.8% | 22.5% | |
| Mar 2026 | $27.39M USD | +12.6% | -6.5% | 26.8% | |
| Mar 2026 | $25.64M USD | -32.0% | -21.5% | 14.6% | |
| Mar 2026 | $17.14M USD | +7.3% | +11.7% | 17.4% | |
| Mar 2026 | $10.64M USD | +101.0% | +25.7% | 14.4% | |
| Mar 2026 | $8.85M USD | +13.5% | +5.6% | 31.0% | |
| Mar 2026 | $3.51M USD | -18.9% | -24.2% | 2.8% | |
| Peer median (excluding UTMD) | — | +13.7% | +3.2% | 20.0% | |
Competitors are the stored peer set for UTMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 60.97M | 75.05M | 92.87M | 82.98M | 85.76M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5.13M | 5.54M | 3.39M | 4.09M | 3.52M |
| Inventory | 6.6M | 8.81M | 9.58M | 8.81M | 7.94M |
| Other Current Assets | 1K | 0 | 429K | 448K | 529K |
| Total Current Assets | 73.16M | 89.92M | 106.27M | 96.33M | 97.74M |
| Property, Plant & Equipment (Net) | 10.62M | 10.22M | 10.55M | 9.76M | 9.91M |
| Goodwill | 14.1M | 13.35M | 13.69M | 13.58M | 14.05M |
| Intangible Assets | 17.76M | 10.38M | 4.95M | 2.87M | 840K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Assets | 42.48M | 33.96M | 29.19M | 26.21M | 24.8M |
| Total Assets | 115.64M | 123.87M | 135.46M | 122.54M | 122.54M |
| Account Payables | 761K | 1.22M | 769K | 543K | 911K |
| Short-term Debt | 0 | 0 | 0 | 56K | 0 |
| Tax Payables | 36K | 337K | 327K | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 96K | 204K | 257K | 55K | 68K |
| Total Current Liabilities | 3.75M | 5.96M | 4.71M | 3.76M | 2.6M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 2.68M | 2.06M | 1.44M | 1.07M | 451K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.68M | 1.26M | 698K | 0 | 0 |
| Total Non-current Liabilities | 4.75M | 3.66M | 2.44M | 1.35M | 676K |
| Total Liabilities | 8.5M | 9.62M | 7.15M | 5.11M | 3.27M |
| Common Stock | 37K | 36K | 36K | 33K | 32K |
| Retained Earnings | 115.31M | 126.01M | 138.34M | 129.3M | 128.65M |
| Accumulated OCI | (9.05M) | (12.04M) | (10.66M) | (11.91M) | (9.42M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 107.14M | 114.25M | 128.31M | 117.43M | 119.27M |
| Total Debt | 396K | 341K | 295K | 338K | 225K |
| Net Debt | (60.58M) | (74.71M) | (92.57M) | (82.69M) | (85.53M) |
Utah Medical Products, Inc.
NASDAQ:UTMD
Intrinsic Alpha fair value
Locked
Current Price
$72.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.